Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#ESMO2024

Home » #ESMO2024
ESMO 2024 | Dr. Dingwei Ye Presents Promising Data on BL-B01D1 for Advanced Urothelial Carcinoma

ESMO 2024 | Dr. Dingwei Ye Presents Promising Data on BL-B01D1 for Advanced Urothelial Carcinoma

Posted by By Mourabit Halima 2024.11.15
At the ESMO 2024 Congress in Barcelona, Dr. Dingwei Ye from Fudan University Shanghai Cancer Center presented findings from a phase 2 study on BL-B01D1, a novel EGFR and HER3…
Read More
ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

Posted by By Lisa Cui 2024.10.28
Amidst the serene morning mist gracing the wutong trees and frost enhancing the ripeness of oranges, the 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) unfolds in…
Read More
Recent Posts
  • ESMO Insights | Professor Barbara Pistilli: Updated VIKTORIA-1 Results Show Sustained Survival Benefit and Improved Safety with Gedatolisib-Based Combinations in PIK3CA-Mutant Advanced Breast Cancer
  • ESMO Insights | Professor Gustavo Werutsky: lidERA BC PRO Results Show Giredestrant Improves Efficacy While Preserving Quality of Life
  • 2026 IFSC | Professor Abdullah Khan: Human Bone Marrow Organoids—A Novel In Vitro Platform for Precision Development in Hematologic Malignancies
  • Professor Shuiping Yin: New Developments and Individualized Strategies in the Treatment of Advanced Renal Cell Carcinoma
  • 10th West China Tianfu Academic Conference on Urologic Oncology | Professor Baijun Dong: From AR Inhibition to Combination Strategies Targeting Multiple Pathways—Exploring New Approaches to Overcoming Treatment Resistance in Prostate Cancer
Recent Comments
    Archives
    • November 2026
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top